実践!　みためだけじゃない画像診断

出版社： メディカ出版
著者：
発行日： 2016-10-05
分野： 臨床医学：内科  >  呼吸器一般
ISBN： 9784840453615
電子書籍版： 2016-10-05 （電子書籍版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,060 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,060 円(税込)

購入する

商品紹介

心エコーやCT、MRIなど画像診断は目覚ましい発展を遂げているが、画像診断だけに頼りすぎてはいけない。各モダリティの特徴を知り、身体所見や聴診のしっかりとした知識を身につけた上で、画像診断を上乗せすることができれば、診療能力は格段にアップする。

目次

  • 実践！　みためだけじゃない画像診断

    ―目次―

    【第1章 虚血性心疾患】
    ◆1　急性冠症候群と不安定狭心症
    ◆2　心電図を活かす
    ◆3　狭心症の解剖学的画像診断と生理学的画像診断
    ◆4　画像診断を活かしてPCIを行う
    ◆5　冠動脈CTを診断・治療にどう活かすか
    ◆6　梗塞心筋をいかに評価するか

    【第2章 弁膜症とSHD（structural heart disease）】
    ◆1　弁膜症と画像診断
    ◆2　大動脈弁狭窄症
    ◆3　大動脈弁狭窄症とTAVI
    ◆4　大動脈弁逆流症
    ◆5　僧帽弁逆流症
    ◆6　感染性心内膜炎
    ◆7　心房中隔欠損症
    ◆8　僧帽弁閉鎖不全症とMitraClip(R)

    【第3章 心不全・心筋症】
    ◆1　心エコーによる心機能評価
    ◆2　ストレインを用いた新しい心機能評価
    ◆3　左室だけが心臓ではない
    ◆4　CT/MRIを用いた心機能評価
    ◆5　拡大心と拡張型心筋症
    ◆6　肥大心と肥大型心筋症
    ◆7　補助人工心臓（VAD）と完全人工心臓（TAH）の現状と未来
    ◆8　収縮性心膜炎の診断と画像診断の位置づけ
    ◆9　たこつぼ型心筋症

    【第4章 大動脈・末梢血管疾患】
    ◆1　大動脈・末梢血管疾患と画像診断
    ◆2　大動脈炎症候群
    ◆3　大動脈瘤の治療と画像診断
    ◆4　大動脈瘤に対するステントグラフト治療
    ◆5　腹部大動脈瘤とEVAR
    ◆6　胸部大動脈瘤とTEVAR
    ◆7　急性大動脈症候群
    ◆8　偽腔閉塞型急性大動脈解離
    ◆9　頸動脈狭窄症の画像診断と治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 虚血性心疾患

P.25 掲載の参考文献
1) Fuster, V. et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 326 (4), 1992, 242-50.
PubMed
2) Fuster, V. et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 326 (4), 1992, 310-8.
 
3) Virmani, R. et al. Lessons from sudden coronary death : a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 20 (5), 2000, 1262-75.
 
4) Stary, HC. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 92 (5), 1995, 1355-74.
 
5) Jia, H. et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 63 (19), 2013, 1748-58.
 
6) Kume, T. et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J. 152 (4), 2006, 755. e1-4.
 
7) Vergallo, R. et al. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque : a 3-vessel optical coherence tomography study. Am Heart J. 167 (1), 2014, 59-67.
PubMed
8) Tian, J. et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma : a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol. 63 (21), 2014, 2209-16.
PubMed
9) Shimamura, K. et al. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients : An optical coherence tomography study. Atherosclerosis. 235 (2), 2014, 532-7.
PubMed
10) Narula, J. et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 61 (10), 2013, 1041-51.
PubMed
11) Stone, G. et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 364 (3), 2011, 226-35.
 
12) Ohtani, T. et al. Number of yellow plaque detected in a coronary artery is associated with future risk of acute coronary syndrome : Detection of vulnerable patients by angioscopy. J Am Coll Cardiol. 47 (11), 2006, 2194-200.
 
13) Komukai, K. et al. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography : The EASY-FIT Study. J Am Coll Cardiol. 64 (21), 2014, 2207-17.
 
14) Hattori, K. et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. J Am Coll Cardiol Img. 5 (2), 2012, 169-77.
 
15) Park, SJ. et al. Effect of statin treatment on modifying plaque composition : a double-blind, randomized study. J Am Coll Cardiol. 67 (15), 2016, 1772-83.
PubMed
16) Nishio, R. et al. Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma. Atherosclerosis. 234 (1), 2014, 114-9.
 
17) Urban, D. et al. Targeting the proprotein convertase subtilisin/kexin type 9 (PCSK9) for the treatment of dyslipidemia and atherosclerosis. J Am Coll Cardiol. 62 (16), 2013, 1401-8.
PubMed
18) Blom, DJ. et al. A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia. N Engl J Med. 370 (19), 2014, 1809-19.
 
19) Sullivan, D. et al. Effect of a monoclonal antibody to PCSK 9 on low-density lipoprotein cholesterol levels in statin intolerant patients : the GAUSS randomized trial. JAMA. 308 (23), 2012, 2497-506.
 
20) Karanasos, A. et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol. 64 (22), 2014, 2343-56.
 
P.35 掲載の参考文献
1) Zimetbaum, PJ. et al. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 348 (10), 2003, 933-40.
PubMed
2) Sgarbossa, EB. et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med. 334 (8), 1996, 481-7.
 
3) Smith, SW. et al. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 60 (6), 2012, 766-76.
 
4) Schroder, R. et al. Extent of early ST segment elevation resolution : a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 26 (7), 1995, 1657-64.
 
5) De Lemos, JA. et al. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 38 (5), 2001, 1283-94.
PubMed
P.48 掲載の参考文献
1) Pijls NH, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 334, 1996, 1703-8.
PubMed
2) Pijls NH, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis : 5-year follow-up of the DEFER Study. 49, 2007, 2105-11.
PubMed
3) Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease : 2 -year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. 56, 2010, 177-84.
PubMed
4) De Bruyne B, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med.371, 2014, 1208-17.
PubMed
P.64 掲載の参考文献
1) Parise, H. et al. Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol. 107 (3), 2011, 374-82.
PubMed
2) Steinvil, A. et al. Intravascular ultrasound-guided drug-eluting stent implantation : An updated meta-analysis of randomized control trials and observational studies. Int J Cardiol. 216, 2016, 133-9.
PubMed
3) Witzenbichler, B. et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents : the assessment of dual antiplatelet therapy with drugeluting stents (ADAPT-DES) study. Circulation. 129 (4), 2014, 463-70.
PubMed
4) Hong, SJ. et al. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation : The IVUS-XPL Randomized Clinical Trial. JAMA. 314 (20), 2015, 2155-63.
PubMed
5) Windecker, S. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization : The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 35 (37), 2014, 2541-619.
 
6) Jia, R. et al. Impact of attenuated plaques on TIMI grade flow and clinical outcomes of coronary artery disease patients : a systematic review and meta analysis. J Thorac Dis. 8 (3), 2016, 527-36.
PubMed
7) Morino, Y. et al. Intravascular ultrasound criteria for determination of optimal longitudinal positioning of sirolimus-eluting stents. Circ J. 74 (8), 2010, 1609-16.
PubMed
8) Gerber, RT. et al. Defining a new standard for IVUS optimized drug eluting stent implantation : the PRAVIO study. Catheter Cardiovasc Interv. 74 (2), 2009, 348-56.
PubMed
9) Sonoda, S. et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation : serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 43 (11), 2004, 1959-63.
 
10) Hong, MK. et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimuseluting stent implantation. Eur Heart J. 27 (11), 2006, 1305-10.
PubMed
11) Song, HG. et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 83 (6), 2014, 873-8.
PubMed
12) Kubo, T. et al. Superficial calcium fracture after PCI as assessed by OCT. J Am Coll Cardiol Img. 8 (10), 2015, 1228-9.
 
13) Shimamura, K. et al. Outcomes of everolimus-eluting stent incomplete stent apposition : a serial optical coherence tomography analysis. Eur Heart J Cardiovasc Imaging. 16 (1), 2015, 23-8.
PubMed
14) Soeda, T. et al. Incidence and clinical significance of poststent optical coherence tomography findings : one-year follow-up study from a multicenter registry. Circulation. 132 (11), 2015, 1020-9.
PubMed
15) Gonzalo, N. et al. Relation between plaque type and dissections at the edges after stent implantation : An optical coherence tomography study. Int J Cardiol. 150 (2), 2011, 151-5.
PubMed
16) Tada, T. et al. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions : a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Eur Heart J Cardiovasc Imaging. 16 (10), 2015, 1101-11.
PubMed
17) Ligthart, JM. et al. Three-dimensional optical coherence tomography for guidance of complex percutaneous coronary interventions. J Am Coll Cardiol Intv. 7 (1), 2014, 102-3.
 
18) Allahwala, UK. et al. Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention. EuroIntervention. 10 (10), 2015, 1154-9.
PubMed
19) Viceconte, N. et al. Frequency domain optical coherence tomography for guidance of coronary stenting. Int J Cardiol. 166 (3), 2013, 722-8.
PubMed
20) Ozaki, Y. et al. Comparison of contrast media and low-molecular-weight dextran for frequencydomain optical coherence tomography. Circ J. 76 (4), 2012, 922-7.
PubMed
21) Kubo, T. et al. OCT compared with IVUS in a coronary lesion assessment : the OPUS-CLASS study. J Am Coll Cardiol Img. 6 (10), 2013, 1095-104.
 
22) Habara, M. et al. Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance. Circ Cardiovasc Interv. 5 (2), 2012, 193-201.
PubMed
23) Kubo, T. et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial) : Study protocol for a randomized controlled trial. J Cardiol. 2016 in press.
 
P.80 掲載の参考文献
1) 2013 ESC guidelines on the management of stable coronary artery disease : the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 34 (38), 2013, 2949-3003.
 
2) Genders, TS. et al. Prediction model to estimate presence of coronary artery disease : retrospective pooled analysis of existing cohorts. BMJ. 344, 2012, e3485.
PubMed
3) American College of Cardiology Foundation Task Force on Expert Consensus Document. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography : a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 55 (23), 2010, 2663-99.
 
4) 循環器病の診断と治療に関するガイドライン (2007-2008年度合同研究班報告). 冠動脈病変の非侵襲的診断法に関するガイドライン. 日本循環器学会編. Circ J. 73 (Suppl III), 2009.
 
5) 船橋伸禎. 心臓CTの使い方 : 現在のコンセンサス (心CT). 東京, 文光堂, 2011, 11.
 
6) Douglas, PS. et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 372 (14), 2015, 1291-300.
PubMed
7) Motoyama, S. et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 50 (4), 2007, 319-26.
PubMed
8) Greenland, P. et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain : a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 49 (3), 2007, 378-402.
 
9) Koo, BK. et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 58 (19), 2011, 1989-97.
 
10) Min, JK, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 308 (12), 2012, 1237-45.
PubMed
11) Norgaard, BL. et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease : the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography : Next Steps). J Am Coll Cardiol. 63 (12), 2014, 1145-55.
 
12) Douglas, PS. et al. Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease : the prospective longitudinal trial of FFR (CT) : outcome and resource impacts study. Eur Heart J. 36 (47), 2015, 3359-67.
PubMed
13) Hirohata, K. et al. A novel CT-FFR method for the coronary artery based on 4D-CT image analysis and structual and fluid analysis. Proc. SPIE, Medical Imaging. 9412 : 94122O ; doi : 10. 1117/12. 2081674. 2015.
 
P.87 掲載の参考文献
1) Gerber, BL. et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography : comparison with contrast-enhanced magnetic resonance. Circulation. 113 (6), 2006, 823-33.
PubMed
2) 矢部敦士ほか. Magnetic Resonance Imaging (MRI) を使用した心筋遅延造影撮影においてのコントラストの描出と心筋バイアビリティーの評価. 厚生連医誌. 21 (1), 2012, 49-55.
 

第2章 弁膜症とSHD ( structural heart disease )

P.92 掲載の参考文献
1) Iung, B. et al. A prospective survey of patients with valvular heart disease in europe : The euro heart survey on valvular heart disease. Eur Heart J. 24 (13), 2003, 1231-43.
PubMed
P.104 掲載の参考文献
1) Ross, J, et al. Aortic stenosis. Circulation. 38 (Suppl 1), 1968, 61-7.
 
2) Nishimura, RA. et al. 2014 aha/acc guideline for the management of patients with valvular heart disease : A report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 63, 2014, e57-185.
 
3) Omran, H. et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis : A prospective, randomised study. Lancet. 361 (9365), 2003, 1241-6.
PubMed
4) American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) : developed in collaboration with the Society of Cardiovascular Anesthesiologists : endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 114 (5), 2006, e84-231.
 
5) Thaden, JJ. et al. Doppler imaging in aortic stenosis : The importance of the nonapical imaging windows to determine severity in a contemporary cohort. J Am Soc Echocardiogr. 28 (7), 2015, 780-5.
 
6) Feuchtner, GM. et al. Multislice computed tomography for detection of patients with aortic valve stenosis and quantification of severity. J Am Coll Cardiol. 47 (7), 2006, 1410-7.
PubMed
7) Lembcke, A. et al. Quantification of aortic valve stenosis : Head-to-head comparison of 64-slice spiral computed tomography with transesophageal and transthoracic echocardiography and cardiac catheterization. Invest Radiol. 44 (1), 2009, 7-14.
PubMed
8) Minners, J. et al. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J. 29 (8), 2008, 1043-8.
PubMed
9) Hachicha, Z. et al. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 115 (22), 2007, 2856-64.
PubMed
10) Jander, N. et al. Outcome of patients with low-gradient"severe"aortic stenosis and preserved ejection fraction. Circulation. 123 (8), 2011, 887-95.
PubMed
11) Tribouilloy, C. et al. Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction : Characteristics, outcome, and implications for surgery. J Am Coll Cardiol. 65 (1), 2015, 55-66.
PubMed
P.130 掲載の参考文献
1) Smith, CR. et al. Transcatheter versus surgical aortic valve replacement in high-risk patients. N Engl J Med. 364, 2011, 2187-98.
PubMed
2) Kodali, SK. et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 366 (18), 2012, 1688-95.
 
3) Adams, DH. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med. 370, 2014, 1790-98.
PubMed
4) Reardon, MJ. et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 66 (2), 2015, 113-21.
 
5) Thyregod, HG. et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis. J Am Coll Cardiol. 65, 2015, 2184-94.
PubMed
6) Leon, MB. et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 374, 2016, 1609-20.
 
7) Koehler, T. et al. Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement. Biomed Res Int. 2015, 572681.
PubMed
8) Zamorano, JL. et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 32 (17), 2011, 2189-214.
PubMed
9) Holmes, DR Jr. et al. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 59, 2012, 1200-54.
PubMed
10) Achenbach, S. et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI) /transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 6 (6), 2012, 366-80.
PubMed
11) Pasic, M. et al. Annular rupture during transcatheter aortic valve replacement : classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc Interv. 8 (1 Pt A), 2015, 1-9.
 
12) Ribeiro, HB. et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation : insights from a large multicenter registry. J Am Coll Cardiol. 62 (17), 2013, 1552-62.
PubMed
13) Toggweiler, S. et al. Management of Vascular Access in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 6 (7), 2013, 643-53.
PubMed
14) Toggweiler, S. et al. Management of Vascular Access in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 6 (8), 2013, 767-76.
PubMed
15) Greif, M. et al. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart. 100 (9), 2014, 691-5.
PubMed
16) Hahn, RT. et al. Recommendations for Comprehensive Intraprocedural Echocardiographic Imaging During TAVR. JACC Cardiovasc Interv. 8 (3), 2015, 261-87.
 
17) Pislaru, SV. et al. Assessment of Prosthetic Valve Function After TAVR. JACC Cardiovasc Imaging. 9 (2), 2016, 193-206.
PubMed
18) Oh, JK. et al. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve : An Observation From the CoreValve U. S. Pivotal Trial. JACC Cardiovasc Imaging. 8 (12), 2015, 1364-75,
PubMed
P.148 掲載の参考文献
1) Movsowitz, HD. et al. Transesophageal echocardiographic description of the mechanisms of aortic regurgitation in acute type A aortic dissection : implications for aortic valve repair. J Am Coll Cardiol. 36 (3), 2000, 884-90.
PubMed
2) Dujardin, KS. et al. Mortality and morbidity of aortic regurgitation in clinical practice. A longterm follow-up study. Circulation. 99 (14), 1999, 1851-7.
PubMed
3) Catherine, M. Otto. et al., eds. Valvular Heart Disease. 4th ed. Philadelphia, Saunders, 2014, 488p.
 
4) Zoghbi, WA. et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 16 (7), 2003, 777-802.
PubMed
5) Detaint, D. et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation : a prospective study. JACC Cardiovasc Imaging. 1 (1), 2008, 1-11.
PubMed
6) Zeitoun, DM. et al. Comparison of Semiquantitative and Quantitative Assessment of Severity of Aortic Regurgitation : Clinical Implications. J Am Soc Echocardiogr. 24 (11), 2011, 1246-52.
 
7) Nishimura, RA. 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 63 (22), 2014, e57-185.
 
8) Bourguignon, T. et al. Very long-term outcomes of the carpentier-edwards perimount valve in aortic position. Ann Thorac Surg. 99 (3), 2015, 1239-47.
 
9) Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). et al. Guidelines on the management of valvular heart disease (version 2012). European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 33 (19), 2012, 2451-96.
 
10) Lansac, E. et al. Valve sparing root replacement : the remodeling technique with external ring annuloplasty. Ann Cardiothorac Surg. 2 (1), 2013, 117-23.
PubMed
11) Sievers, HH. et al. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 133 (5), 2007, 1226-33.
PubMed
12) Aicher, D. et al. Valve configuration determines long-term results after repair of the bicuspid aortic valve. Circulation. 123, 2011, 178-85.
PubMed
13) Boodhwani, M. et al. Repair-oriented classification of aortic insufficiency : impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 137 (2), 2009, 286-94.
PubMed
14) 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 弁膜疾患の非薬物治療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf (2016年7月閲覧)
 
15) Svensson, LG. et al. Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures : Executive Summary. Ann Thorac Surg. 95 (4), 2013, 1491-505.
PubMed
16) Erbel, R. et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 35 (41), 2014, 2873-926.
 
17) Schafers, HJ. et al. A new approach to the assessment of aortic cusp geometry. J Thorac Cardiovasc Surg. 132 (2), 2006, 436-8.
 
18) Pethig, K. et al. Aortic valve reimplantation in ascending aortic aneurysm risk factors for early valve failure. Ann Thorac Surg. 73 (1), 2002, 29-33.
PubMed
P.163 掲載の参考文献
1) Nishimura, RA. et al. 2014 aha/acc guideline for the management of patients with valvular heart disease : A report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 63, 2014, e57-185.
 
2) Lamas, GA. et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and ventricular enlargement investigators. Circulation. 96 (3), 1997, 827-33.
PubMed
3) Kang, DH. et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 119 (6), 2009, 797-804.
PubMed
4) Ngaage, DL. et al. Influence of preoperative atrial fibrillation on late results of mitral repair : is concomitant ablation justified?. Ann Thorac Surg. 84 (2), 2007, 434-42. discussion 442-33.
 
5) Ghoreishi, M. et al. Pulmonary hypertension adversely affects short-and long-term survival after mitral valve operation for mitral regurgitation : Implications for timing of surgery. J Thorac Cardiovasc Surg. 142 (6), 2011, 1439-52.
 
6) Kitai, T. et al. Early surgery for asymptomatic mitral regurgitation : Importance of atrial fibrillation. J Heart Valve Dis. 21 (1), 2012, 61-70
PubMed
7) Enriquez-Sarano, M. et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 91 (4), 1995, 1022-8.
PubMed
8) Moss, RR. et al. Outcome of mitral valve repair or replacement : A comparison by propensity score analysis. Circulation. 108 (Suppl 1), 2003, II90-7.
PubMed
9) Gillinov, AM. et al. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg. 135 (4), 2008, 885-93, 893. e1-2
 
10) Delgado, V. Assessment of mitral valve anatomy and geometry with multislice computed tomography. JACC Cardiovasc Imaging. 2 (5), 2009, 556-65.
PubMed
11) Kim, K. et al. Mechanism of asymmetric leaflet tethering in ischemic mitral regurgitation : 3D analysis with multislice CT. JACC Cardiovasc imaging. 2012, 5 (2), 230-2.
PubMed
12) Kim, K. et al. Interpapillary muscle distance independently affects severity of functional mitral regurgitation in patients with systolic left ventricular dysfunction. J Thorac Cardiovasc Surg. 2014, 148 (2), 434.
PubMed
13) Acker, MA. et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 370 (1), 2014, 23-32.
PubMed
14) Kwon, MH. et al. Functional, ischemic mitral regurgitation : To repair or not to repair?. Circulation. 125, 2012, 2563-5.
PubMed
15) Smith, PK. et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 371, 2014, 2178-88.
PubMed
P.176 掲載の参考文献
1) Cahill, TJ. et al. Infective endocarditis. Lancet. 387, 2016, 882-93.
PubMed
2) Habib, G. et al. 2015 esc guidelines for the management of infective endocarditis : The task force for the management of infective endocarditis of the european society of cardiology (esc). Endorsed by : European association for cardio-thoracic surgery (eacts), the european association of nuclear medicine (eanm). Eur Heart J. 36 (44), 2015, 3075-128.
 
3) Selton-Suty, C. et al. Preeminence of staphylococcus aureus in infective endocarditis : A 1-year population-based survey. Clin Infect Dis. 54 (9), 2012, 1230-9.
PubMed
4) Song, JK. Infective endocarditis involving an apparently structurally normal valve : New epidemiological trend?. Korean J Intern Med. 30 (4), 2015, 434-42.
PubMed
5) Li, JS. et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 30 (4), 2000, 633-8.
 
6) Bruun, NE. et al. Cardiac imaging in infectious endocarditis. Eur Heart J. 35, 2014, 624-32.
PubMed
7) Prendergast, BD. et al. Surgery for infective endocarditis : Who and when?. Circulation. 121, 2010, 1141-52.
PubMed
8) Feuchtner, GM. et al. Multislice computed tomography in infective endocarditis : Comparison with transesophageal echocardiography and intraoperative findings. J Am Coll Cardiol. 53 (5), 2009, 436-44.
PubMed
9) Pizzi, MN. et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18f-fluordeoxyglucose positron emission tomography/computed tomography angiography : Initial results at an infective endocarditis referral center. Circulation. 132 (12), 2015, 1113-26.
PubMed
10) Funakoshi, S. et al. Impact of early surgery in the active phase on long-term outcomes in leftsided native valve infective endocarditis. J Thorac Cardiovasc Surg. 142 (4), 2011, 836-42 e831.
 
11) Kang, DH. et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 366, 2012, 2466-73.
PubMed
12) Murdoch, DR. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century : The international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 169 (5), 2009, 463-73.
PubMed
13) Amat-Santos, IJ. et al. Infective endocarditis after transcatheter aortic valve implantation : Results from a large multicenter registry. Circulation. 131, 2015, 1566-74.
PubMed
P.191 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 成人先天性心疾患診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_niwa_h.pdf (2016年5月閲覧)
 
2) Nakagawa, K. et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv. 80 (1), 2012, 84-90.
 
3) Campbell, M. Natural history of atrial septal defect. Br Heart J. 32 (6), 1970, 820-6.
PubMed
4) 赤木禎治ほか. "未治療の成人先天性心疾患の病態と治療". 成人先天性心疾患パーフェクトガイド. 東京, 文光堂, 2015, 124-30.
 
5) 日本循環器学会. 先天性心疾患, 心臓大血管の構造的疾患 (structural heart disease) に対するカテーテル治療のガイドライン. 2015, 185p.
 
6) Jategaonkar, S. et al. Percutaneous closure of atrial septal defects : echocardiographic and functional results in patients older than 60 years. Circ Cardiovasc Interv. 2, 2009, 85-9.
PubMed
7) Huang, X. et al. En face view of atrial septal defect by two-dimensional transthoracic echocardiography : comparison to real-time three-dimensional transesophageal echocardiography. J Am Soc Echocardiogr. 23 (7), 2010, 714-21.
 
8) Takaya, Y. et al. Long-term outcome after transcatheter closure of atrial septal defect in older patients : impact of age at procedure. JACC Cardiovasc Interv. 8 (4), 2015, 600-6.
PubMed
9) Baumgartner, H. et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 31 (23), 2010, 2915-57.
PubMed
10) Amin, Z. et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects : review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 63 (4), 2004, 496-502.
PubMed
11) Webb, G. et al. St. Jude Medical AMPLATZER Atrial Septal Occluder Executive Summary. Circulation 2006. 114, 2012, 1645-53.
 
P.204 掲載の参考文献
1) Mirabel, M. et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J. 28 (11), 2007, 1358-65.
PubMed
2) Feldman, T. et al. Percutaneous mitral repair with the MitraClip system : safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 54 (8), 2009, 686-94.
PubMed
3) Boekstegers, P. et al. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol. 103 (2), 2014, 85-96.
PubMed
4) Feldman, T. et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 364, 2011, 1395-406.
 
5) Maisano, F. et al. Percutaneous mitral valve interventions in the real world : early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 62 (12), 2013, 1052-61.
 
6) Eggebrecht, H. et al. Risk and outcomes of complications during and after MitraClip implantation : Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter Cardiovasc Interv. 86 (4), 2015, 728-35.
PubMed
7) Neuss, M. et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail. 15 (7), 2013, 786-95.
PubMed
8) Kaneko, H. et al. Interaction between renal function and percutaneous edge-to-edge mitral valve repair using MitraClip. J Cardiol. 2016. (Epub ahead of print)
 
9) Enriquez-Sarano, M. et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 90 (2), 1994, 830-7.
PubMed
10) Lesevic, H. et al. Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction. Am J Cardiol. 116 (5), 2015, 749-56.
PubMed
11) Kaneko, H. et al. Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip. Heart Vessels. 2016. (Epub ahead of print)
 
12) Franzen, O. et al. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 13, 2011, 569-76.
 

第3章 心不全・心筋症

P.216 掲載の参考文献
1) Douglas, PS. et al. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 13 (2), 1989, 311-5.
PubMed
2) Quinones, MA. et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the solvd registry and trials : Significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol. 35 (5), 2000, 1237-44.
PubMed
3) Grayburn, PA. et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure : The beta-blocker evaluation of survival trial (best). J Am Coll Cardiol. 45 (7), 2005, 1064-71.
 
4) Dini, FL. et al. Patterns of left ventricular remodeling in chronic heart failure : Prevalence and prognostic implications. Am Heart J. 161 (6), 2011, 1088-95.
PubMed
5) Cintron, G. et al. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The v-heft va cooperative studies group. Circulation. 87 (6 Suppl), 1993, VI17-23.
 
6) Brignole, M. et al. 2013 esc guidelines on cardiac pacing and cardiac resynchronization therapy : The task force on cardiac pacing and resynchronization therapy of the european society of cardiology (esc). Developed in collaboration with the european heart rhythm association (ehra). Eur Heart J. 34 (29), 2013, 2281-329.
 
7) Nikitin, NP. et al. Prognostic value of systolic mitral annular velocity measured with doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart. 92 (6), 2006, 775-9.
PubMed
8) Dini, FL. et al. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. Am J Cardiol. 89 (5), 2002, 518-23.
PubMed
9) Ghio, S. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 37 (1), 2001, 183-8.
PubMed
10) Yamamoto, K. et al. Determination of left ventricular filling pressure by doppler echocardiography in patients with coronary artery disease : Critical role of left ventricular systolic function. J Am Coll Cardiol. 30 (7), 1997, 1819-26.
PubMed
11) Yamaguchi, H. et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol. 43 (1), 2004, 55-60.
PubMed
12) Nagueh, SF. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography : An update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 29 (4), 2016, 277-314.
PubMed
13) Pecini, R. et al. The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure. Eur J Heart Fail. 13 (10), 2011, 1121-5.
PubMed
14) Beigel, R. et al. Noninvasive evaluation of right atrial pressure. J Am Soc Echocardiogr. 26 (9), 2013, 1033-42.
PubMed
P.225 掲載の参考文献
1) Kawagishi, T. Speckle tracking for assessment of cardiac motion and dyssynchrony. Echocardiography. 25 (10), 2008, 1167-71.
PubMed
2) Lang, RM. et al. Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 28 (1), 2015, 1-39.
PubMed
3) Yingchoncharoen, T. et al. Normal ranges of left ventricular strain : a meta-analysis. J Am Soc Echocardiogr. 26 (2), 2013, 185-91.
 
4) Ishizu, T. et al. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertension. 63 (3), 2014, 500-6.
PubMed
5) Phelan, D. et al. Relative apical sparing of longitudinal strain using two-dimensional speckletracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 98 (19), 2012, 1442-8.
 
6) Koyama, J. et al. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging. 3 (4), 2010, 333-42.
PubMed
7) Banypersad, SM. et al. Updates in cardiac amyloidosis : a review. J Am Heart Assoc. 1 (2), 2012, e000364.
PubMed
8) Sato, K. et al. Prognostic value of global longitudinal strain in paradoxical low-flow, low-gradient severe aortic stenosis with preserved ejection fraction. Circ J. 78 (11), 2014, 2750-9.
PubMed
9) Kusunose, K. et al. Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ Cardiovasc Imaging. 7 (6), 2014, 938-45.
PubMed
10) Pandis, D. et al. Assessment of longitudinal myocardial mechanics in patients with degenerative mitral valve regurgitation predicts postoperative worsening of left ventricular systolic function. J Am Soc Echocardiogr. 27 (6), 2014, 627-38.
PubMed
11) Takigiku, K. et al. Normal range of left ventricular 2-dimensional strain : Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) study. Circ J. 76 (11), 2012, 2623-32.
PubMed
12) Farsalinos, KE. et al. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors : The EACVI/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr. 28 (10), 2015, 1171-81.
PubMed
P.235 掲載の参考文献
1) Valsangiacomo, Buechel ER. et al. Imaging the right heart : The use of integrated multimodality imaging. Eur Heart J. 33 (8), 2012, 949-60.
PubMed
2) Haddad, F. et al. Right ventricular function in cardiovascular disease, part i : Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 117 (11), 2008, 1436-48.
PubMed
3) Rudski, LG. et al. Guidelines for the echocardiographic assessment of the right heart in adults : A report from the american society of echocardiography endorsed by the european association of echocardiography, a registered branch of the european society of cardiology, and the canadian society of echocardiography. J Am Soc Echocardiogr. 23 (7), 2010, 685-713 ; quiz 786-688.
 
4) Hoit, BD. Left atrial size and function : Role in prognosis. J Am Coll Cardiol. 63, 2014, 493-505.
PubMed
5) Lang, RM. et al. Recommendations for cardiac chamber quantification by echocardiography in adults : An update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 28, 2015, 1-39 e14.
 
6) Nagueh, SF. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography : An update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 29 (4), 2016, 277-314.
PubMed
P.239 掲載の参考文献
1) Tee, M. Imaging techniques for cardiac strain and deformation : comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography. Expert Rev Cardiovasc Ther. 11 (2), 2013, 221-31.
PubMed
P.250 掲載の参考文献
1) Maron, BJ. et al. Contemporary definitions and classification of the cardiomyopathies : an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee ; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups ; and Council on Epidemiology and Prevention. Circulation. 113 (14), 2006, 1807-16.
PubMed
2) Elliott, P. et al. Classification of the cardiomyopathies : a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 29 (2), 2008, 270-6.
 
3) 友池仁暢ほか. 循環器病の診断と治療に関するガイドライン (2009-2010年度合同研究班報告). 拡張型心筋症ならびに関連する二次性心筋症の診療に関するガイドライン. http://www.j-circ.or.jp/guideline/pdf/JCS2011_tomoike_h.pdf (2016年5月閲覧)
 
4) Quinones, MA. et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials : significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 35 (5), 2000, 1237-44.
PubMed
5) Lang, RM. et al. Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 28 (1), 2015, 1-39 e14.
 
6) Takigiku, K. et al. Normal range of left ventricular 2-dimensional strain : Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE) study. Circ J. 76 (11), 2012, 2623-32.
PubMed
7) Karamitsos, TD. et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 54 (15), 2009, 1407-24.
PubMed
8) Naya, M. et al. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy. J Nucl Med. 50 (2), 2009, 220-5.
PubMed
9) 松崎益徳ほか. 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告). 慢性心不全治療ガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (2016年5月閲覧)
 
10) Cleland, JG. et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 352 (15), 2005, 1539-49.
PubMed
11) Chung, ES. et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 117 (20), 2008, 2608-16.
PubMed
12) Ruschitzka, F. et al. Cardiac-resynchronization therapy in heart failure with a Narrow QRS Complex. N Engl J Med. 369 (15), 2013, 1395-405.
PubMed
P.262 掲載の参考文献
1) Gruner, C. et al. Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 6 (1), 2013, 19-26.
 
2) Binder, J. et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy : septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc. 81 (4), 2006, 459-67.
PubMed
3) Nagueh, SF. et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy : Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 24 (5), 2011, 473-98.
PubMed
4) Henry, WL. et al. Asymmetric septal hypertrophy (ASH) : the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation. 47 (4), 1973, 827-32.
PubMed
5) Serri, K. et al. Global and regional myocardial function quantification by two-dimensional strain : application in hypertrophic cardiomyopathy. J Am Coll Cardiol. 47 (6), 2006, 1175-81.
PubMed
6) Gruner, C. et al. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy. Echocardiography. 29 (7), 2012, 810-7.
PubMed
7) Maron, MS. et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol. 100 (8), 2007, 1293-8.
PubMed
8) Losi, MA. et al. Prognostic significance of left atrial volume dilatation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 22 (1), 2009, 76-81.
PubMed
9) Nagueh, SF. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 99 (2), 1999, 254-61.
PubMed
10) To, AC. et al. Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 4 (10), 2011, 1123-37.
PubMed
11) Sherrid, MV. et al. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 36 (4), 2000, 1344-54.
PubMed
12) Maron, MS. et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 114 (21), 2006, 2232-9.
PubMed
13) Elliott, PM. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 35 (39), 2014, 2733-79.
 
14) Yu, EH. et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy : relationship to obstruction and relief with myectomy. J Am Coll Cardiol. 36 (7), 2000, 2219-25.
PubMed
15) Minami, Y. et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 57 (23), 2011, 2346-55.
PubMed
16) Maron, MS. et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 118 (15), 2008, 1541-9.
PubMed
17) Lang, R. et al. "Pathophysiology and Variants of Hypertrophic Cardiomyopathy". ASE's Comprehens ive Echocardiography. 2nd ed. Philadelphia, A 1903-2899.
 
P.268 掲載の参考文献
1) Mancini, D. et al. Left Ventricular Assist Devices : A Rapidly Evolving Alternative to Transplant. J Am Coll Cardiol. 65 (23), 2015, 2542-55.
PubMed
2) Thoratec. HeartMate II. http://www.thoratec.com/medical-professionals/vad-product-information/heartmate-ll-lvad.aspx
 
3) Kathirvel, S. Mechanical circulatory support. Best Pract Res Clin Anaesthesiol. 29, 2015, 203-27.
 
4) Cook, JA. et al. The total artificial heart. J Thorac Dis. 7 (12), 2015, 2172-80.
PubMed
P.276 掲載の参考文献
1) Bertog, SC. et al. Constrictive pericarditis : etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 43 (8), 2004, 1445-52.
PubMed
2) Adler, Y. et al. 2015 ESC guidelines for the diagnosis and management of pericardial disease. Eur Heart J. 36 (42), 2015, 2921-64.
PubMed
3) Talreja, DR. et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 108 (15), 2003, 1852-7.
PubMed
4) Klein, AL. et al. American society of echocardiography clinical recommendation for multimodality cardiovascular imaging of patients with pericardial disease : endorsed by the society for cardiovascular magnetic resonance and society of cardiovascular computed tomography. J Am Soc Echocardiogr. 26 (9), 2013, 965-1012.
 
5) Ha, JW. et al. Annulus Paradoxus : transmitral flow velocity to mitral annuluar velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 104 (9), 2001, 976-8.
 
6) Cremer, P. et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Cird Cardiovasc Imaging. 8 (5), 2015, e003125.
 
7) Feng, D. et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after anti-inflammatory medical therapy : a pilot study. Circulation. 124 (17), 2011, 1830-7.
PubMed
P.286 掲載の参考文献
1) 児玉和久ほか編. "Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm". 臨床からみた心筋細胞障害 : 虚血から心不全まで. 東京, 科学評論社, 1990, 56-64.
 
2) Citro, R. et al. Echocardiographic Correlates of Acute Heart Failure, Cardiogenic Shock, and In-Hospital Mortality in Tako-Tsubo Cardiomyopathy. JACC Cardiovasc Imaging. 7 (2), 2014, 119-29.
PubMed
3) Templin, C. et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 373 (10), 2015, 929-38.
PubMed
4) Bybee, KA. et al. Systematic review : transient left ventricular apical ballooning : a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 141 (11), 2004, 858-65.
PubMed
5) Prasad, A. et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy) : a mimic of acute myocardial infarction. Am Heart J. 155 (3), 2008, 408-17.
 
6) Kawai, S. et al. Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J. 71 (6), 2007, 990-2.
PubMed
7) Neil, C. et al. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy : evidence from T2-weighted cardiac MRI. Heart. 98 (17), 2012, 1278-84.
PubMed
8) Kobayashi, Y. et al. Left ventricular dysfunction assessed by three-dimensional strain in takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 13, 2012, i59.
 
9) Hurst, RT. et al. Transient midventricular ballooning syndrome : a new variant. J Am Coll Cardiol. 48 (3), 2006, 579-83.
PubMed
10) Song, BG. et al. The clinical characteristics, laboratory parameters, electrocardiographic, and echocardiographic findings of reverse or inverted takotsubo cardiomyopathy : comparison with mid or apical variant. Clin Cardiol. 34 (11), 2011, 693-9.
 
11) Mansencal, N. et al. Apical-sparing variant of Tako-Tsubo cardiomyopathy : prevalence and characteristics. Arch Cardiovasc Dis. 103 (2), 2010, 75-9.
PubMed
12) Kato, K. et al. Transient focal left ventricular ballooning : a new variant of Takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 16 (12), 2015, 1406.
PubMed
13) Kagiyama, N. et al. Impact of right ventricular involvement on the prognosis of takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 17 (2), 2016, 210-6.
PubMed
14) Elesber, AA. et al. Transient cardiac apical ballooning syndrome : prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol. 47 (5), 2006, 1082-3.
PubMed
15) Eitel, I. et al. Biventricular stress-induced (takotsubo) cardiomyopathy with left midventricular and right apical ballooning. Int J Cardiol. 151 (2), 2011, e63-4.
PubMed
16) Citro, R. et al. Right ventricular involvement and pulmonary hypertension in an elderly woman with tako-tsubo cardiomyopathy. Chest. 137 (4), 2010, 973-5.
 
17) Kagiyama, N. et al. Isolated right ventricular takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging. 16 (3), 2015, 285.
PubMed
18) Kawaji, T. et al. Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J. 79 (4), 2015, 839-46.
PubMed
19) Izumo, M. et al. Mechanisms of acute mitral regurgitation in patients with takotsubo cardiomyopathy : an echocardiographic study. Circ Cardiovas Iimaging. 4 (4), 2011, 392-8.
 
20) Naruse, Y. et al. The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy : serial analysis of cardiovascular magnetic resonance images. J Cardiovasc Magn Reson. 13, 2011, 67.
PubMed
21) Nakamori, S. et al. Prevalence and signal characteristics of late gadolinium enhancement on contrast-enhanced magnetic resonance imaging in patients with takotsubo cardiomyopathy. Circ J. 76 (4), 2012, 914-21.
PubMed
22) Brinjikji, W. et al. In-hospital mortality among patients with takotsubo cardiomyopathy : a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 164 (2), 2012, 215-21.
PubMed
23) Sharkey, SW. et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol. 55 (4), 2010, 333-41.
PubMed
24) Okura, H. Echocardiographic assessment of takotsubo cardiomyopathy : beyond apical ballooning. J Echocardiogr. 14 (1), 2015, 13-20.
PubMed

第4章 大動脈・末梢血管疾患

P.302 掲載の参考文献
1) Morgagni, GB. De sedibus et causis morborum per anatome indagatis [Letter 30]. 1761. Article12.
 
2) 高安右人. 奇異なる網膜中心血管の変化の一例. 日本眼科学会雑誌. 12, 1908, 554-5.
 
3) Jennette, JC. et al. 2012 Revised International Chapel hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65 (1), 2013, 1-11.
 
4) Terao, C. et al. Two susceotibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in Japanese population. Am J Hum Gent. 93 (2), 2013, 289-97.
 
5) Hata, A. et al. Angiographic findings of Takayasu arteritis : New classification. Int J Cardiol. 54 (suppl), 1996, S155-64.
 
6) Clifford, A. et al. Aortitis : Outcomes from a Cohort of 196 patients. 2014 American College of Rheumatology Annual Meeting Abstract. 2786.
 
7) Wang, H. et al. Comparison of clinical and pathological characteritcs of isolated aortitis and Takayasu arteritis with ascending aorta involvement. J Clin Pathol. 65 (4), 2012, 362-6.
PubMed
8) Ishihara, T. et al. Sensitive assessment of activity of Takayasu ' s arteritis by pentraxin 3, a new biomarker. J Am Coll Cardiol. 57 (16), 2011, 1712-3.
PubMed
9) Soussan, M. et al. Management of Large-Vessel Vasculitis With FDG-PET. A systemic literature review and meta-analysis. Medicine. 94 (14), 2015, e662.
 
10) Hoffman, GS. Takayasu arteritis : lessons learned from the American National Institute of Health experience. Int J Cardiol. 54 (suppl), 1996, S83-6.
 
11) Tso, E. et al. Takayasu arteritis. Utility and Limitations of Magnetic Resonance Imaging in Diagnosis and Treatment. Arthritis Rheum. 46 (6), 2002, 1634-42.
PubMed
12) Jiang, L. et al. Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol. 155 (2), 2012, 262-7.
PubMed
13) Papa, M. et al. Takayasu Arteritis : Intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR. 198 (3), 2012, W279-84.
PubMed
P.307 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf (2015年5月閲覧).
 
2) Norman, PE. et al. Population based randomized controlled trial on inpact of screening on mortality from abdominal aortic aneurysm BMJ. 329, 2004, 1259.
 
P.316 掲載の参考文献
1) 日本ステントグラフト実施基準管理委員会. http://stentgraft.jp/pro (2016年5月閲覧)
 
2) Kent, KC. et al. Abdominal aortic aneurysm. N Engl J Med. 371 (22), 2014, 2101-8.
PubMed
3) Hughes, GC. et al. "Real world" thoracic endografting : results with the Gore TAG device 2 years after U. S. FDA approval. Ann Thorac Surg. 86 (5), 2008, 1530-8.
PubMed
4) Antoniou, GA. et al. A meta-analysis of outcomes of endovascular abdominal aortic aneurysm repair in patients with hostile and friendly neck anatomy. J Vasc Surg. 57 (2), 2013, 527-38.
PubMed
P.327 掲載の参考文献
1) De Bruin, JL. et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med. 362 (20), 2010, 1881-9.
 
2) Lederle, FA. et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med. 367 (21), 2012, 1988-97.
PubMed
3) The United Kingdom EVAR Trial Investigators. et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med. 362 (2), 2010, 1863-71.
 
4) 高本眞一ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf (2016年5月閲覧)
 
P.338 掲載の参考文献
1) 高本眞一ほか. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf (2016年5月閲覧)
 
2) Nienaber, CA. et al. Endovascular repair of type B aortic dissection. Long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv. 6 (4), 2013, 407-16.
PubMed
P.351 掲載の参考文献
1) Vilacost I. Acute aoritc syndrome. Heart. 85, 2001, 365-8.
 
2) Hagan PG, et al. The International Registry of Acute Aortic Dissection (IRAD). JAMA. 283, 2000, 897-903.
PubMed
3) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf (2015年5月閲覧).
 
4) Evangelista A, et al. Long-Term Outcome of Aortic Dissection With Patent False Lumen. Circulation. 125, 2012, 3133-41.
PubMed
5) Weber T, et al. D-dimer in Acute Aortic Dissection. CHEST. 123, 2003, 1375-8.
 
6) Hazui H, et al, Young adult patients with short dissection length and thrombosed false lumen without ulcer-like projections are liable to habe false-negative results of D-Dimer testing for acute aortic dissection based on a study of 113 cases. Circ J. 70, 2006, 1598-601.
 
7) Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 35, 2014, 2873-926.
 
P.365 掲載の参考文献
1) Krukenberg E. Beitrage zur Frage des Aneurysymas dissecans. Beitr Pathol Anat Allg Pathol. 67, 1920, 329-51.
 
2) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf (2015年5月閲覧).
 
3) Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 35, 2014, 2873-926.
 
4) Hiratzka LF, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with throracic aortic disease. Circulation. 121, 2010, 1544-79.
 
5) Harris KM, et al. Acute Aortic Intramural Hematoma. An analysis from the international registry of acute aortic dissection. Circulation. 126, 2012, S91-6.
PubMed
6) Song JK, et al. Different remodeling of descending thoracic aorta after acute event in aortic intramural hemorrhage versus aortic dissection. Am J Cardiol. 83, 1999, 937-41.
PubMed
7) Kaji S, et al. Long-Term prognosis of patients with type A aortic intramural hematoma. Circulation. 106, 2002, I248-52.
PubMed
8) Kitai T, et al. Clinical outcomes of medical therapy and timely operation in initially diagnosed type A aortic intramural hematoma : 20-year experience. Circulation. 120, 2009, S292-8.
PubMed
9) Kaji S, et al. Long-Term prognosis of patients with type B aortic intramural hematoma. Circulation. 108, 2003, II 307-11.
 
10) Kitai T, et al, Impact of new development of Ulcer-Like projection on clinical outcomes in patients with type B aortic dissection with thrombosed false lumen. Circulation. 122, 2010, S74-80.
PubMed
11) Kitai T, et al. Detection of intimal defect by 64-Row multidetector computed tomography in patients with acute aortic intramural hematoma. Circulation. 124, 2011, S174-8.
PubMed
P.375 掲載の参考文献
1) Stary, HC. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis : a report from The Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 89, 1994, 2462-78.
 
2) Stary, HC. et al. A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis. A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 15 (9), 1995, 1512-31.
 
3) Yoshida, K. et al. Symptomatic low-grade carotid stenosis with intraplaque hemorrhage and expansive arterial remodeling is associated with a high relapse rate refractory to medical treatment. Neurosurgery. 70 (5), 2012, 1143-50.
PubMed
4) Yoshida, K. et al. The association between expansive arterial remodeling detected by highresolution MRI in carotid artery stenosis and clinical presentation. J Neurosurg. 123 (2), 2015, 434-40.
PubMed
5) Ferguson, GG. et al. The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke. 30 (9), 1999, 1751-8.
PubMed
6) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 273 (18), 1995, 1421-28.
PubMed
7) Mathiesen, EB. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis : the tromso study. Circulation. 103 (17), 2001, 2171-5,
PubMed
8) Yamada, N. et al. Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR Am J Neuroradiol. 28 (2), 2007, 287-92.
PubMed
9) Yoshida, K. et al. Characterization of carotid atherosclerosis and detection of soft plaque with use of black-blood MR imaging. AJNR Am J Neuroradiol. 29 (5), 2008, 868-74.
 

書評

最近チェックした商品履歴

Loading...